GPP
Great Point Partners’s PTC Therapeutics PTCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-500,000
| Closed | -$11.2M | – | 42 |
|
|
2023
Q3 | $11.2M | Buy |
+500,000
| New | +$11.2M | 2.04% | 19 |
|
|
2023
Q1 | – | Sell |
-302,135
| Closed | -$11.5M | – | 47 |
|
|
2022
Q4 | $11.5M | Buy |
+302,135
| New | +$11.5M | 2.26% | 18 |
|
|
2020
Q3 | – | Sell |
-330,000
| Closed | -$16.7M | – | 40 |
|
|
2020
Q2 | $16.7M | Sell |
330,000
-1,433,387
| -81% | -$72.7M | 1.34% | 22 |
|
|
2020
Q1 | $78.7M | Buy |
1,763,387
+13,387
| +0.8% | +$597K | 8.22% | 3 |
|
|
2019
Q4 | $84.1M | Sell |
1,750,000
-250,000
| -13% | -$12M | 7.32% | 3 |
|
|
2019
Q3 | $67.6M | Buy |
2,000,000
+25,615
| +1% | +$866K | 6.21% | 5 |
|
|
2019
Q2 | $88.8M | Buy |
1,974,385
+160,125
| +9% | +$7.21M | 9.86% | 2 |
|
|
2019
Q1 | $68.3M | Buy |
1,814,260
+589,260
| +48% | +$22.2M | 6.76% | 1 |
|
|
2018
Q4 | $42M | Buy |
1,225,000
+507,542
| +71% | +$17.4M | 5.31% | 6 |
|
|
2018
Q3 | $33.7M | Sell |
717,458
-851,042
| -54% | -$40M | 5.26% | 8 |
|
|
2018
Q2 | $52.9M | Buy |
1,568,500
+28,678
| +2% | +$967K | 7.33% | 1 |
|
|
2018
Q1 | $41.7M | Buy |
1,539,822
+454,022
| +42% | +$12.3M | 6.19% | 4 |
|
|
2017
Q4 | $18.1M | Sell |
1,085,800
-14,200
| -1% | -$237K | 3.09% | 12 |
|
|
2017
Q3 | $22M | Sell |
1,100,000
-800,000
| -42% | -$16M | 4.28% | 8 |
|
|
2017
Q2 | $34.8M | Buy |
1,900,000
+431,479
| +29% | +$7.91M | 6.24% | 5 |
|
|
2017
Q1 | $14.5M | Buy |
+1,468,521
| New | +$14.5M | 2.87% | 14 |
|